Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for ESLOY and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ESLOY and 80,000+ other tickers.
See exactly how ESLOY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ESLOY and 80,000+ other tickers.
EssilorLuxottica S.A., established in Paris, France, in 1849, is a prominent global entity in the optical industry. The company specializes in the creation, production, and worldwide distribution of a diverse range of vision products, including ophthalmic lenses, eyewear frames, and sunglasses, catering to markets across North America, Europe, Latin America, Asia, Oceania, and Africa. Its extensive operations are divided into five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The Wholesale division is responsible for manufacturing and…
Despite Q2 revenue coming in slightly below consensus, EssilorLuxottica delivered stronger-than-expected operating leverage, with adjusted EBIT margin reaching 18.6% versus market expectations of approximately 16.5%. AI-glasses revenue nearly doubled in Q2, while there is still limited evidence that the category is replacing traditional eyewear purchases. Myopia-management sales increased 24% in Q2, while the partnership with Applied Materials strengthens EssilorLuxottica's position in next-generation smart eyewear and should improve product scalability over time.
EssilorLuxottica (EL/ESLOF) has declined nearly 30% in the past year, despite continued profitable growth and expansion into medtech and big-data. Three major growth pillars—myopia management, smart eyewear, and integrated hearing aids—are expanding EL's addressable market but currently suppress profitability. Forward P/E has compressed to 22x, below its 10-year average, yet still implies high growth expectations amid increased competition and margin pressure.
EssilorLuxottica ADR (ESLOY) Q2 2026 Earnings Call Transcript
The Franco-Italian manufacturer of Oakley and Ray-Ban sunglasses booked 8.7% year-over-year organic growth in the three months through June, losing a little pace from the 11% growth it recorded in the first three months of the year.
Meta and EssilorLuxottica have launched a new collection of artificial intelligence (AI) glasses called Meta Glasses that is designed to be accessible to a broader audience than the Ray-Ban Meta, Oakley Meta, Meta Ray-Ban Display and Ray-Ban Meta Optics AI glasses the companies already offer. The new Meta Glasses start at $299, Essilor Luxottica said in a Tuesday (June 23) press release.